DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

company name or ticker

India Just Did What Millions of Americans Wish the U.S. Government Would Do

India's National Pharmaceutical Pricing Authority levies a game-changing decision this past week meant to improve access to branded medications. Find out how this action could both help and hurt India's citizens, and why it would be nearly impossible to implement in the United States.

Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% - Tale of the Tape

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape

Evolving Portfolio - Identifying New Ideas

Actions Semiconductor Leads Declines Among Asian ADRs After Cutting Revenue Guidance

Dr Reddy Laboratories Ltd Stock Upgraded (RDY)

Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield

‘Reddy’ to Consider This Generic Stock?

Dr. Reddy's is an Indian generic drug maker that is well poised for global and local growth in an environment where innovation is faltering and patent protection expiration are negatively affecting big pharma companies.

Celgene's Vidaza Disappoints in Phase III Study - Analyst Blog

ICICI Bank Leads Declines in India's ADRs After Mumbai Stock Exchange Falls on Iraq Conflict